ARCHIVES

No Difference in Toxicity Between IMRT and PRT In Medicare Patients

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

Bioassay Backlog To Be Cleared Up In Year: Squire

November 26, 1976

Hybridoma Cell Lines Available from NCI

September 3, 1982

Report Urges Changes To Cut Activation Times For NCI Phase III Trials.

April 9, 2010

HHS News: Skin Cancer Awareness Initiative Begun

May 29, 1998

ORI Finds Misconduct By CIT Professor

August 4, 1995

AGS-003 Increased Survival In Combination with Sunitinib

February 24, 2012